BusinessPhoto: TradingViewBeOne Medicines Thrives Amid US-China Biotech Tensions
BeOne Medicines, a $50 billion biotech company founded in China and headquartered in Switzerland, reported strong quarterly earnings driven by its leading cancer drugs. Despite rising geopolitical tensions between Beijing and Washington over biotech, the company remains financially robust and continues to perform well in the global market.
TradingView·




